[en] A 73-year-old man developed an ill-defined fatal vasculitis involving the central nervous system. The case report was published as a clinicopathologic exercise in February 1995 in The New England Journal of Medicine.(1) We restudied the pathologic material and found both varicella tester virus (VZV) DNA and VZV-specific antigen, but not herpes simplex virus (HSV) or cytomegalovirus (CMV) DNA or HSV- or CMV-specific antigen, in three of the five cerebral arteries examined. The inflammatory response, disruption of the internal elastic lamina, and detection of viral antigen were patchy from one artery to another, as well as within a given artery. A search for VZV should be conducted in cases of vasculitis when both the central and peripheral nervous systems are involved, when focal narrowing is present in large arteries, when brain imaging reveals infarction in gray and white matter, both deep and superficial, and when white matter is disproportionally involved. Zosteriform rash is not required for diagnosis.
Disciplines :
Immunology & infectious disease
Author, co-author :
Gilden, D. H.; University of Colorado Denver Health Science Programs - UCD
Kleinschmidt-DeMasters, B. K.; University of Colorado Denver Health Science Programs - UCD
Wellish, M.; University of Colorado Denver Health Science Programs - UCD
Hedley-Whyte, E. T.; Massachusetts General Hospital, Harvard Medical School, Boston MA
Rentier, Bernard ; Université de Liège - ULiège > Département de Microbiologie > Virologie fondamentale et Immunologie
Mahalingam, R.; University of Colorado Denver Health Science Programs - UCD
Language :
English
Title :
Varicella-zoster virus : a cause of waxing and waning vasculitis. The New England Journal of Medicine case 5-1995 revisited
Publication date :
1996
Journal title :
Neurology
ISSN :
0028-3878
eISSN :
1526-632X
Publisher :
Lippincott Williams & Wilkins, Hagerstown, United States - Maryland
Case Records of the Massachusetts General Hospital (Case 5-1995). N Engl J Med 1995;332:452-459.
Gilden DH, Dueland AN, Devlin ME, Mahalingam R, Cohrs R. Varicella-zoster virus reactivation without rash. J Infect Dis 1992;166(S1):S30-34.
Amlie-Lefond C, Kleinschmidt-DeMasters BK, Mahalingam R, Davis LE, Gilden DH. The vasculopathy of varicella zoster virus encephalitis. Ann Neurol 1995;37:784-790.
Gressens P, Martin JR. In situ polymerase chain reaction: localization of HSV-2 DNA sequences in infections of the nervous system. J Virol Methods 1994;46:61-83.
Debrus S, Sadzot-Delvaux C, Nikkels AF, Piette J, Rentier B. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 1995;69:3240-3245.
Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. Zoster sine herpete, a clinical variant. Ann Neurol 1994;35:530-533.
Gilden DH, Beinlich BR, Rubinstien EM, et al. Varicella-zoster virus myelitis: an expanding spectrum. Neurology 1994; 44:1818-1823.
Dueland AN, Devlin M, Martin JR, et al. Fatal varicella zoster virus meningoradiculitis without skin involvement. Ann Neurol 1991;29:569-572.
Snoeck R, Gérard M, Sadzot-Delvaux C, et al. Meningo-radiculo-neuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. J Med Virol 1994;42:338-347.